Jim Simons’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$725K Sell
317,913
-89,500
-22% -$206K ﹤0.01% 2428
2025
Q4
$1.14M Sell
407,413
-283,387
-41% -$1.01M ﹤0.01% 2202
2025
Q3
$3.32M Sell
690,800
-163,450
-19% -$1.04M ﹤0.01% 1731
2025
Q2
$7.77M Sell
854,250
-54,600
-6% -$402K 0.01% 1236
2025
Q1
$8.21M Sell
908,850
-169,250
-16% -$1.79M 0.01% 1115
2024
Q4
$14.1M Sell
1,078,100
-90,000
-8% -$1.2M 0.02% 811
2024
Q3
$18.3M Sell
1,168,100
-78,500
-6% -$1.19M 0.03% 715
2024
Q2
$16.8M Buy
1,246,600
+176,250
+16% +$3.61M 0.03% 669
2024
Q1
$29.7M Sell
1,070,350
-236,621
-18% -$5.25M 0.05% 478
2023
Q4
$25.2M Buy
1,306,971
+168,471
+15% +$3.05M 0.04% 529
2023
Q3
$18.4M Sell
1,138,500
-25,200
-2% -$447K 0.03% 605
2023
Q2
$22.2M Sell
1,163,700
-15,700
-1% -$280K 0.03% 630
2023
Q1
$17.2M Sell
1,179,400
-314,800
-21% -$5.64M 0.02% 805
2022
Q4
$29.2M Buy
1,494,200
+193,800
+15% +$3.78M 0.04% 543
2022
Q3
$31.3M Sell
1,300,400
-161,800
-11% -$4.99M 0.04% 475
2022
Q2
$46M Sell
1,462,200
-67,750
-4% -$2.45M 0.05% 390
2022
Q1
$67.3M Sell
1,529,950
-110,000
-7% -$4.72M 0.08% 274
2021
Q4
$71.3M Sell
1,639,950
-170,700
-9% -$6.69M 0.09% 239
2021
Q3
$56.7M Sell
1,810,650
-496,550
-22% -$19.5M 0.07% 280
2021
Q2
$97.7M Sell
2,307,200
-59,500
-3% -$2.31M 0.12% 162
2021
Q1
$89M Sell
2,366,700
-714,000
-23% -$22.3M 0.11% 183
2020
Q4
$83.3M Buy
3,080,700
+24,600
+0.8% +$633K 0.09% 228
2020
Q3
$76.7M Buy
3,056,100
+649,050
+27% +$9.47M 0.08% 273
2020
Q2
$18.3M Sell
2,407,050
-624,450
-21% -$4.57M 0.02% 868
2020
Q1
$27.7M Buy
3,031,500
+538,250
+22% +$3.25M 0.03% 617
2019
Q4
$12.9M Buy
2,493,250
+1,240,216
+99% +$7.96M 0.01% 1285
2019
Q3
$7.28M Buy
1,253,034
+426,484
+52% +$1.91M 0.01% 1593
2019
Q2
$2.65M Buy
826,550
+456,100
+123% +$1.56M ﹤0.01% 2185
2019
Q1
$1.52M Buy
+370,450
New +$2.34M ﹤0.01% 2468
2018
Q1
Sell
-93,850
Closed -$1.77M 3514
2017
Q4
$1.77M Buy
93,850
+68,100
+264% +$1.51M ﹤0.01% 2412
2017
Q3
$752K Sell
25,750
-517,000
-95% -$15.3M ﹤0.01% 2673
2017
Q2
$17.5M Buy
542,750
+317,800
+141% +$10.4M 0.02% 928
2017
Q1
$7.78M Buy
+224,950
New +$8.03M 0.01% 1411
2016
Q2
Sell
-410,450
Closed -$16.6M 3462
2016
Q1
$16.6M Buy
410,450
+171,600
+72% +$6.39M 0.03% 771
2015
Q4
$8.59M Buy
238,850
+210,400
+740% +$7.61M 0.02% 1093
2015
Q3
$909K Sell
28,450
-347,300
-92% -$11.8M ﹤0.01% 2423
2015
Q2
$12.8M Buy
375,750
+212,300
+130% +$7.15M 0.03% 786
2015
Q1
$5.53M Buy
163,450
+67,700
+71% +$2.36M 0.01% 1294
2014
Q4
$3.36M Buy
+95,750
New +$3.22M 0.01% 1510
2014
Q3
Sell
-337,150
Closed -$11.5M 2916
2014
Q2
$11.5M Sell
337,150
-150,573
-31% -$5.16M 0.03% 765
2014
Q1
$17.1M Buy
487,723
+417,173
+591% +$14.7M 0.04% 564
2013
Q4
$2.58M Buy
+70,550
New +$2.59M 0.01% 1603

Other funds holding ACH

Jim Simons's ACH Position: Q1 2026 in Review

Jim Simons reduced its Accendra Health (ACH) stake by 22% in Q1 2026, selling an estimated $206K and leaving 317,913 shares worth $725K. The position accounts for ﹤0.01% of the portfolio, ranked #2428.

Jim Simons first reported a position in ACH in Q4 2013 and has held it in 42 quarters since. The position peaked at $97.7M in Q2 2021. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • Jim Simons held 317,913 shares of Accendra Health worth $725K as of Q1 2026.
  • Jim Simons sold 89,500 Accendra Health shares in Q1 2026, an estimated $206K.
  • Accendra Health made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #2428 holding.
  • Jim Simons first reported a position in Accendra Health in Q4 2013 and has held it in 42 quarters since.
  • Jim Simons's Accendra Health position peaked at $97.7M in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.